NCT00006063 Randomized Study of Pancrelipase With Bicarbonate (PANCRECARB) Capsules in Reducing Steatorrhea in Patients With Cystic Fibrosis Status COMPLETED Phase NA
NCT00005112 Growth Hormone Use in Cystic Fibrosis - a Multicenter Study Status COMPLETED Phase PHASE3
NCT00005110 A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic Fibrosis Status SUSPENDED Phase NA
NCT00004829 Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis Status COMPLETED Phase PHASE3
NCT00004806 Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis Status COMPLETED Phase PHASE1
NCT00004779 Phase I Pilot Study of Ad5-CB-CFTR, an Adenovirus Vector Containing the Cystic Fibrosis Transmembrane Conductance Regulator Gene, in Patients With Cystic Fibrosis Status COMPLETED Phase PHASE1
NCT00004747 Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis Status COMPLETED Phase PHASE2
NCT00004705 Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic Fibrosis Status COMPLETED Phase NA
NCT00004533 Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients With Cystic Fibrosis Status COMPLETED Phase PHASE1
NCT00004489 Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis Status COMPLETED Phase NA
NCT00004471 Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer Status COMPLETED Phase PHASE1
NCT00004441 Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis Status COMPLETED Phase NA
NCT00004440 Study of Ibuprofen to Preserve Lung Function in Patients With Cystic Fibrosis Status COMPLETED Phase NA
NCT00004428 Phase I Randomized Study of CPX for the Treatment of Adult Patients With Mild Cystic Fibrosis Status COMPLETED Phase PHASE1
NCT00004315 Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease Status UNKNOWN Phase PHASE2
NCT00004296 Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients Status COMPLETED Phase N/A
NCT00004287 Phase I Study of the Third Generation Adenovirus H5.001CBCFTR in Patients With Cystic Fibrosis Status COMPLETED Phase PHASE1